NOVELION THERAPEUTICS

novelion-therapeutics-logo

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.

#SimilarOrganizations #People #Financial #Website #More

NOVELION THERAPEUTICS

Industry:
Biopharma Biotechnology Therapeutics

Founded:
1981-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.novelion.com

Total Employee:
251+

Status:
Active

Contact:
604.707.7000

Email Addresses:
[email protected]

Total Funding:
72 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Amazon Virginia Region OVH Mimecast Akamai Hosted


Similar Organizations

avalo-therapeutics-logo

Avalo Therapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company.


Current Advisors List

mark-corrigan_image

Mark Corrigan Board Member @ Novelion Therapeutics
Board_member
2017-04-01

Current Employees Featured

not_available_image

Robert L. Butchofsky
Robert L. Butchofsky President & CEO @ Novelion Therapeutics
President & CEO

not_available_image

Cameron R. Nelson
Cameron R. Nelson CFO @ Novelion Therapeutics
CFO

Founder


julia-levy_image

Julia Levy

Stock Details


Company's stock symbol is NASDAQ:NVLN

Acquisitions List

Date Company Article Price
2016-06-15 Aegerion Pharmaceuticals Aegerion Pharmaceuticals acquired by Novelion Therapeutics N/A

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Novelion Therapeutics

Investments List

Date Company Article Money raised
2015-06-08 Aralez Pharmaceuticals Novelion Therapeutics investment in Post-IPO Equity - Aralez Pharmaceuticals 350 M USD

Official Site Inspections

http://www.novelion.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Novelion Therapeutics"

Novelion Therapeutics Inc. | Alvarez & Marsal - Alvarez and Marsal

Jan 16, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Announces Completion of Plan of Liquidation and …

Mar 10, 2023 The final distribution was comprised of approximately US$2.47 million (US$0.125/share), representing the aggregate of the cash remaining in Novelion, including the …See details»

Novelion Announces Completion of Plan of Liquidation and

Mar 10, 2023 Shareholders whose shares in Novelion were held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Announces Completion of Plan of Liquidation and …

Mar 10, 2023 Shareholders whose shares in Novelion were held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Provides Update on Final Distribution to Registered …

Jun 28, 2021 VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s …See details»

Novelion Therapeutics Inc. - AnnualReports.com

Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of …See details»

Novelion Therapeutics - Crunchbase Company Profile & Funding

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with …See details»

Novelion Therapeutics Provides Update on Liquidation Process

Sep 30, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Therapeutics Inc. - Press Release | Alvarez & Marsal ...

Novelion Provides Update on Final Distribution to Registered Shareholders. Access all Engagement updates and court filed materials for all active engagements in which either …See details»

Novelion Therapeutics Inc (NVLNF) Profile - The Globe and Mail

See the company profile for Novelion Therapeutics Inc (NVLNF) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»

Novelion Therapeutics Provides Update on Liquidation Process

Sep 30, 2020 Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “Liquidator”) today provides an update …See details»

Novelion Provides Update on Final Distribution to Registered ...

Jun 28, 2021 VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., …See details»

Novelion Announces Date of Final Distribution to Registered

Mar 28, 2022 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Announces Date of Interim Distribution to Registered …

Mar 4, 2021 VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s …See details»

Novelion Therapeutics Provides Update on Liquidation

Sep 30, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Announces Date of Final Distribution to Registered …

Mar 28, 2022 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Announces Court Approval for Interim Distribution

Dec 23, 2020 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Announces Date of Interim Distribution to Registered ...

Mar 4, 2021 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Announces Date of Interim Distribution to

Mar 4, 2021 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

Novelion Provides Update on Interim Distribution to Registered ...

Jan 26, 2021 Shareholders whose shares in Novelion are held in a brokerage firm or with a securities dealer, trust company, bank or another similar organization, are encouraged to …See details»

linkstock.net © 2022. All rights reserved